Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
10.74
Dollar change
-0.10
Percentage change
-0.92
%
Index- P/E- EPS (ttm)-0.15 Insider Own- Shs Outstand65.63M Perf Week-6.61%
Market Cap720.76M Forward P/E65.09 EPS next Y0.17 Insider Trans- Shs Float- Perf Month-3.58%
Income-10.22M PEG- EPS next Q0.01 Inst Own0.03% Short Float- Perf Quarter-3.37%
Sales245.74M P/S2.93 EPS this Y123.50% Inst Trans- Short Ratio1.07 Perf Half Y-9.21%
Book/sh3.20 P/B3.36 EPS next Y368.09% ROA-2.29% Short Interest0.00M Perf Year-20.15%
Cash/sh3.18 P/C3.38 EPS next 5Y- ROE-4.82% 52W Range9.70 - 16.71 Perf YTD-6.04%
Dividend Est.- P/FCF- EPS past 5Y- ROI-2.65% 52W High-35.73% Beta0.15
Dividend TTM- Quick Ratio3.41 Sales past 5Y12.03% Gross Margin93.14% 52W Low10.72% ATR (14)0.56
Dividend Ex-Date- Current Ratio4.16 EPS Y/Y TTM-174.65% Oper. Margin-11.68% RSI (14)42.82 Volatility1.81% 3.73%
Employees- Debt/Eq0.78 Sales Y/Y TTM19.67% Profit Margin-4.16% Recom1.00 Target Price26.44
Option/ShortNo / Yes LT Debt/Eq0.76 EPS Q/Q82.06% Payout0.00% Rel Volume0.19 Prev Close10.84
Sales Surprise13.05% EPS Surprise-988.89% Sales Q/Q48.66% EarningsMar 14 BMO Avg Volume2.54K Price10.74
SMA20-5.07% SMA50-9.42% SMA200-9.44% Trades Volume476 Change-0.92%
Mar-14-24 02:00AM
Feb-29-24 02:00AM
Feb-08-24 02:00AM
Jan-08-24 01:29AM
01:00AM
01:00AM Loading…
Dec-13-23 01:00AM
Nov-21-23 01:00AM
Nov-10-23 08:51AM
Nov-07-23 02:00AM
Nov-01-23 03:00AM
Oct-26-23 01:00AM
Oct-12-23 02:00AM
Sep-25-23 10:00AM
Aug-24-23 02:00AM
Aug-14-23 01:00AM
01:00AM Loading…
Aug-09-23 01:00AM
Aug-03-23 01:00AM
Jul-18-23 01:00AM
Jul-13-23 02:00AM
Jun-01-23 01:00AM
May-25-23 02:00AM
May-17-23 11:28AM
May-11-23 01:00AM
Apr-26-23 02:00AM
Apr-19-23 02:00AM
01:36AM
Apr-13-23 06:00AM
Apr-11-23 01:00AM
Apr-05-23 02:00AM
01:00AM
10:39AM Loading…
Mar-30-23 10:39AM
Mar-24-23 02:51PM
Mar-13-23 05:43AM
03:15AM
Mar-12-23 03:55PM
02:30PM
Feb-28-23 01:00AM
Feb-21-23 01:00AM
Feb-16-23 01:00AM
Dec-15-22 08:55AM
01:00AM
Dec-12-22 08:50AM
Dec-07-22 01:00AM
Dec-01-22 09:40AM
Nov-28-22 02:36AM
Nov-23-22 08:50AM
01:00AM
Nov-08-22 12:20PM
Nov-03-22 02:00AM
Nov-02-22 02:00AM
Oct-31-22 12:55AM
Oct-28-22 01:00AM
Oct-27-22 01:00AM
Oct-18-22 09:40AM
Oct-12-22 01:00AM
Oct-11-22 01:00AM
Sep-28-22 09:13AM
01:00AM
Sep-07-22 01:00AM
Aug-04-22 01:00AM
Aug-02-22 01:00AM
Aug-01-22 01:00AM
Jul-25-22 01:00AM
Jun-02-22 09:26AM
May-18-22 01:11PM
May-12-22 01:00AM
May-05-22 01:00AM
Apr-26-22 01:00AM
Apr-22-22 01:00AM
Apr-06-22 04:00PM
Apr-01-22 11:45AM
Mar-28-22 01:00AM
Mar-26-22 08:11AM
Mar-17-22 02:00AM
Mar-08-22 01:00AM
Feb-02-22 10:22AM
01:00AM
Jan-06-22 01:00AM
Dec-23-21 01:00AM
Nov-02-21 06:54PM
Oct-28-21 03:05PM
01:00AM
Oct-22-21 01:00AM
Sep-14-21 01:00AM
Aug-05-21 01:00AM
Jul-20-21 01:00AM
Jul-01-21 10:35AM
01:38AM
01:00AM
Jun-23-21 01:00AM
Jun-18-21 01:00AM
Jun-04-21 01:00AM
Jun-01-21 01:00AM
May-19-21 04:31PM
May-17-21 01:00AM
May-13-21 01:00AM
Apr-22-21 01:00AM
Apr-07-21 04:00PM
Apr-06-21 05:30PM
Mar-23-21 02:00AM
Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following geographical segments: the United States, Europe, and Rest of the World. The company was founded on November 11, 1988 and is headquartered in Leiden, the Netherlands.